Holen Sie sich die Stockscreener-App
15.08
2.65%
-0.41
Handel nachbörslich:
15.07
-0.010
-0.07%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TEVA?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$15.49
Offen:
$15.49
24-Stunden-Volumen:
7.84M
Relative Volume:
0.72
Marktkapitalisierung:
$17.28B
Einnahmen:
$16.54B
Nettoeinkommen (Verlust:
$-1.64B
KGV:
-10.40
EPS:
-1.45
Netto-Cashflow:
$749.00M
1W Leistung:
-6.34%
1M Leistung:
-7.60%
6M Leistung:
-13.63%
1J Leistung:
+6.87%
1-Tages-Spanne:
$14.87
$15.50
1-Wochen-Bereich:
$14.87
$16.28
52-Wochen-Spanne:
$12.51
$22.80
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Company Profile
Firmenname
Teva Pharmaceutical Industries Ltd Adr
Sektor
Telefon
972 (3) 914-8213
Adresse
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, TEL AVIV
Vergleichen Sie TEVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
15.08 | 17.28B | 16.54B | -1.64B | 749.00M | -1.45 |
|
ZTS
Zoetis Inc
|
163.11 | 73.07B | 9.26B | 2.49B | 2.30B | 5.47 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.05 | 47.43B | 30.25B | 1.37B | 5.08B | 0.4257 |
|
HLN
Haleon Plc Adr
|
10.24 | 45.72B | 14.35B | 1.85B | 0 | 0.4023 |
|
ITCI
Intra Cellular Therapies Inc
|
131.81 | 14.03B | 612.78M | -86.37M | -62.91M | -0.87 |
Teva Pharmaceutical Industries Ltd Adr Stock (TEVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-07-10 | Hochstufung | Argus | Hold → Buy |
| 2024-03-08 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-12 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-01-23 | Hochstufung | Jefferies | Hold → Buy |
| 2024-01-03 | Hochstufung | Piper Sandler | Underweight → Neutral |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-11-27 | Hochstufung | UBS | Neutral → Buy |
| 2023-07-06 | Hochstufung | UBS | Sell → Neutral |
| 2023-05-25 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2023-05-18 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-01-19 | Herabstufung | Jefferies | Buy → Hold |
| 2022-11-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2022-11-04 | Herabstufung | UBS | Neutral → Sell |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-08-05 | Hochstufung | BofA Securities | Neutral → Buy |
| 2022-06-14 | Fortgesetzt | UBS | Neutral |
| 2022-05-17 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-05-04 | Herabstufung | Piper Sandler | Neutral → Underweight |
| 2022-04-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2022-03-25 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2022-01-27 | Herabstufung | Argus | Buy → Hold |
| 2021-10-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2021-05-04 | Herabstufung | UBS | Buy → Neutral |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Sector Perform |
| 2020-11-25 | Eingeleitet | Oppenheimer | Perform |
| 2020-08-06 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2020-07-27 | Fortgesetzt | Goldman | Neutral |
| 2020-06-01 | Hochstufung | SunTrust | Hold → Buy |
| 2020-04-24 | Fortgesetzt | Citigroup | Neutral |
| 2020-04-06 | Hochstufung | UBS | Neutral → Buy |
| 2020-02-24 | Herabstufung | Edward Jones | Hold → Sell |
| 2019-11-12 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2019-10-17 | Hochstufung | Gabelli & Co | Hold → Buy |
| 2019-08-07 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-07-19 | Eingeleitet | Wolfe Research | Peer Perform |
| 2019-07-15 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2019-07-10 | Fortgesetzt | Credit Suisse | Neutral |
| 2019-07-05 | Hochstufung | Argus | Hold → Buy |
| 2019-06-11 | Eingeleitet | Barclays | Underweight |
| 2019-06-03 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2019-05-30 | Herabstufung | BofA/Merrill | Buy → Underperform |
| 2019-05-28 | Herabstufung | UBS | Buy → Neutral |
| 2019-03-20 | Eingeleitet | SunTrust | Hold |
| 2019-03-07 | Fortgesetzt | UBS | Buy |
Alle ansehen
Teva Pharmaceutical Industries Ltd Adr Aktie (TEVA) Neueste Nachrichten
What will the future hold for CarGurus Inc (NASDAQ:CARG) stock? - US Post News
Billionaire Stanley Druckenmiller Jettisoned Shares of Palantir and Nvidia, and Is Piling Into 3 High-Profile Turnaround Stocks - The Motley Fool
Teva Pharmaceutical Stock Scores RS Rating Upgrade - MSN
IBD Rating Upgrades: Teva Pharmaceutical ADR Flashes Improved Relative Price Strength - Investor's Business Daily
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
How does TEVA’s price to cash per share ratio compare in the market? - US Post News
Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Validea Detailed Fundamental AnalysisTEVA - Nasdaq
Why weight-loss drugs are the top target of Medicare price negotiations - Equities News
Investor Network: Teva Pharmaceutical Industries Limited Sponsored ADR to Host Earnings Call - ACCESS Newswire
Is the SM Energy Co (NYSE:SM) stock an investment opportunity? - US Post News
Teva Pharmaceutical Stock: Strategic Global Access Initiatives Advance - sharewise
Are Clear Secure Inc’shares a good deal? - US Post News
Molina Healthcare Inc (MOH) stock on the rise: An overview - US Post News
Stocktwits teva sales - Texas is Life
Teva- Pharmaceutical Industries Ltd. ADR’s: Contrasting Stock Performances in a Volatile Market - The InvestChronicle
FHN’s Stock Market Expedition: Traversing Gains and Losses in 2023 - The InvestChronicle
Has Hesai Group Sponsored ADR (HSAI) Outpaced Other Auto-Tires-Trucks Stocks This Year? - Yahoo Finance
Recent Insider Activity Could Benefit Dover Corp (DOV) - Knox Daily
Analyzing Northern Trust Corp (NTRS) After Recent Trading Activity - Knox Daily
Understanding the Risks of Investing in QuinStreet Inc (QNST) - Knox Daily
why Teva- Pharmaceutical Industries Ltd. ADR [TEVA] is a Good Choice for Investors After New Price Target of $24.71 - The DBT News
fuboTV Inc [FUBO] is 213.49% higher this YTD. Is it still time to buy? - The DBT News
Teva- Pharmaceutical Industries Ltd. ADR (TEVA)’s stock price in review: A technical analysis - US Post News
Tilray Brands Inc (TLRY)’s stock price range in the last year - US Post News
AGNC Investment Corp (AGNC) stock analysis: A simple moving average approach - US Post News
What is the investor’s view on Nebius Group N.V (NBIS)? - US Post News
U.S. Bancorp (USB) Stock: A Closer Look at the Market Potential - The News Heater
Evaluating the Impact of 0.95 Increase on NIO Inc ADR’s (NIO) Stock - The News Heater
Comerica, Inc [CMA] Officer makes an insider purchase of 1,630 shares worth 0.11 million. - Knox Daily
Selling Buzz: Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Director MIGNONE ROBERTO sells 286,000 shares of the company – Knox Daily - Knox Daily
Vice President Thomson Andrew Justin Mackenzi sale 4,047 shares of T. Rowe Price Group Inc [TROW] - Knox Daily
SoundHound AI Inc [SOUN] stock for 409,436 USD was sold by MARCUS LAWRENCE - Knox Daily
Investors in cash trouble should check out Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - SETE News
Selling Buzz: Interpublic Group Of Cos., Inc [IPG] SVP, Controller & CAO CARROLL CHRISTOPHER F sells 18,382 shares of the company – Knox Daily - Knox Daily
United Community Banks Inc [UCB] Records 200-Day SMA of $29.14 - Knox Daily
There is no way Arrowhead Pharmaceuticals Inc (ARWR) can keep these numbers up - SETE News
A better buy-in window may exist right now for Sotera Health Co (SHC) - SETE News
Wall Street analysts’ outlook for Hamilton Lane Inc (HLNE) - SETE News
Insider Selling: MOSLEY WILLIAM D, Seagate Technology Holdings Plc [STX] Chief Executive Officer divested 20,000 shares – Knox Daily - Knox Daily
Confluent Inc [CFLT] stock for 113,437 USD was sold by Phan Kong - Knox Daily
A company insider recently sold 16,932 shares of Kroger Co [KR]. Should You Sale? - Knox Daily
3 Generic Drug Stocks to Watch - Morningstar
SaverOne Expands Driver Safety System Deployment with Teva Pharmaceutical - TipRanks
Teva- Pharmaceutical Industries Ltd. ADR (TEVA) Stock: Navigating a Year of Stock Volatility - The InvestChronicle
Keeping an Eye on Omnicom Group, Inc (OMC) After Insider Trading Activity - Knox Daily
Understanding the Risks of Investing in Teva- Pharmaceutical Industries Ltd. ADR (TEVA) - Knox Daily
TEVA Stock Quote Price and Forecast - CNN
Finanzdaten der Teva Pharmaceutical Industries Ltd Adr-Aktie (TEVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.05%
0.74%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):